Education, honesty, and communication skills are key for both patient and dermatologist when it comes to creating treatment regimens.
In a video with Dermatology Times®, James Q. Del Rosso, DO, discusses his presentation “What’s News in the Medicine Chest” at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs.
In a hard-hitting session from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, April Armstrong, MD, MPH, dove into PAD technology and future innovations in psoriasis treatment.
Dermavant’s new topical treatment for plaque psoriasis in adults was approved by the FDA this morning.
Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
The risks of certain comorbid conditions varied between the 2 groups of patients.
In this week’s Pointers with Dr Portela, the 208SkinDoc hosts a podcast called, “Between Two Derms.” This week he covers cases in the clinic, psoriasis at the Met Gala and more.
UCB announced the FDA issued a CRL that stated that the FDA cannot approve the BLA in its current form.
In the world of pediatric dermatology, many skin conditions can have parents concerned about their children’s condition. Lisa Swanson, MD, explains how to better address their questions at the 3rd Annual Society of Dermatology Nurse Practitioners Symposium.
At the opening session of the Society of Dermatology Nurse Practitioners Annual Symposium, Kathleen Haycraft, DNP, FNP-BC, DCNP, FAANP, delved into the revolutionary and evolutionary advances shaping dermatology in 2022.